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Saccharomyces cerevisiae cells lacking the cytochrome c oxidase (CcO) assembly factor Coa2 are impaired in
Cox1 maturation and exhibit a rapid degradation of newly synthesized Cox1. The respiratory deficiency of
coa2⌬ cells is suppressed either by the presence of a mutant allele of the Cox10 farnesyl transferase involved
in heme a biosynthesis or through impaired proteolysis by the disruption of the mitochondrial Oma1 protease.
Cox10 with an N196K substitution functions as a robust gain-of-function suppressor of the respiratory
deficiency of coa2⌬ cells but lacks suppressor activity for two other CcO assembly mutant strains, the coa1⌬
and shy1⌬ mutants. The suppressor activity of N196K mutant Cox10 is dependent on its catalytic function and
the presence of Cox15, the second enzyme involved in heme a biosynthesis. Varying the substitution at Asn196
reveals a correlation between the suppressor activity and the stabilization of the high-mass homo-oligomeric
Cox10 complex. We postulate that the mutant Cox10 complex has enhanced efficiency in the addition of heme
a to Cox1. Coa2 appears to impart stability to the oligomeric wild-type Cox10 complex involved in Cox1
hemylation.

translocase (16). Newly synthesized Cox1 is escorted through
the maturation process by IM-associated protein complexes
containing Mss51, Cox14, Coa1, and Shy1. The initial Cox1
assembly intermediate involves a complex with Mss51 and
Cox14 (3, 27). Cox14 is not important for the translational
initiation function of Mss51, since cox14⌬ cells synthesize Cox1
but are stalled in its maturation presumably due to the failure
to form the newly synthesized Cox1-Mss51 complex (3, 27).
Coa1 appears to coordinate the transition of newly synthesized
Cox1 from the Mss51-Cox14 complex to a later intermediate
involving Shy1 that likely functions in the heterobimetallic
heme-copper center (23, 28). Cells lacking Coa1 or Shy1 synthesize Cox1, but maturation is largely stalled prior to cofactor
insertion, leading to Cox1 degradation. Limited assembly of
CcO occurs in either deficient strain, but the residual CcO is
insufficient to promote respiratory growth.
Clues to the CcO assembly pathway have been gleaned by
the isolation of genetic suppressors of respiration-deficient
strains (1). Overexpression of MSS51 in shy1⌬ cells yields
respiratory growth, most likely through elevated Cox1 translation (2). Mss51 was proposed to be sequestered in a nonproductive complex in shy1⌬ cells, thereby limiting its level for
Cox1 translation initiation (3). Overexpression of Hap4, the
catalytic subunit of the Hap2/3/4/5 transcription complex, suppresses the CcO deficiency of shy1⌬ cells through induced
expression of nucleus-encoded subunits of CcO (10). Enhanced levels of Cox5a and Cox6 may stabilize Cox1 in shy1⌬
cells, enabling progression to later stages of CcO assembly. A
series of extragenic suppressors of the coa1⌬ cell respiratory
defect was isolated (28). High-copy-number MSS51 was an
efficient suppressor of coa1⌬ cells, and three weaker suppressors were high-copy-number COX10, MDJ1, and COA2. As
described, Cox10 is involved in the biosynthesis of heme a,
Mdj1 is a DnaJ cochaperone with Hsp70, and Coa2 is a newly
identified CcO assembly factor. Strong synergism was observed

Cytochrome c oxidase (CcO) is the terminal enzyme of the
energy-transducing respiratory chain in mitochondria. Eukaryotic CcO consists of 12 to 13 subunits, with three mitochondrion-encoded subunits (Cox1 to Cox3) forming the core enzyme embedded within the mitochondrial inner membrane
(IM). The remaining nucleus-encoded subunits pack on the
periphery of the catalytic core (35). The assembled holoenzyme is further organized into supercomplexes with the bc1
cytochrome c reductase (8). The core CcO subunits contain
three copper atoms and two modified heme cofactors (34).
Cox1 contains both heme moieties, one of which exists as a
heterobinuclear center with copper. Cox2 contains the other
two Cu ions within a binuclear copper center. Two modifying
enzymes, Cox10 and Cox15, form the modified heme moiety in
CcO. Cox10 catalyzes the conversion of heme b into heme o by
the addition of a hydroxyethyfarnesyl group (12). Cox15 converts heme o into heme a through the oxidation of a C8 pyrrole
methyl moiety (11). Cox15, heme a synthase, works in conjunction with ferredoxin and ferredoxin reductase (4).
The biogenesis of CcO, occurring within the IM, commences
with the mitochondrial synthesis of the Cox1 subunit, followed
by stepwise insertion of the heme and copper redox cofactors
and the addition of the remaining subunits. The translation of
Cox1 on mitoribosomes occurs in juxtaposition to the IM and
is mediated in yeast by the IM-tethered translational activators
Pet309 and Mss51 (21, 22, 27, 32). Mdm38 and Mba1 facilitate
recruitment of mitoribosomes for Cox1 translation (26, 30).
Nascent Cox1 appears to be inserted into the IM by the Oxa1
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TABLE 1. S. cerevisiae yeast strains used in this study
Strain

Genotype

BY4741
BY4741 coa2⌬
BY4743
BY4743 cox10⌬
BY4743 coa1⌬
BY4743 shy1⌬
W303
W303 coa2⌬
W303 cox10⌬
W303 coa1⌬
W303 cox4⌬
W303 cox11⌬
W303 oma1⌬
W303 coa2⌬yta12⌬
W303 coa2⌬yme1⌬
W303 coa2⌬oma1⌬
W303 coa2⌬cox15⌬
DY5113 (W303)
COX10-3HA
COX10-13Myc
COX10-13Myc mss51⌬
COX10-13Myc cox14⌬
COX10-13Myc coa1⌬
COX10-13Myc shy1⌬
COX10-13Myc sco1⌬
COX10-13Myc cox1⌬
COX15-13Myc
SHY1-13Myc
SHY1-13Myc cox11⌬
COA1-13Myc
COX1-3HA

MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 coa2::kanMX4
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
BY4743 cox10::kanMX4
BY4743 coa1::kanMX4
BY4743 shy1::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1
W303 coa2::kanMX4
W303 cox10::HIS3
W303 coa1::kanMX4
W303 cox4::CaURA3
W303 cox11::HIS3
W303 oma1::CaURA3
W303 coa2::CaURA3 yta12::kanMX4
W303 coa2::CaURA3 yme1::kanMX4
W303 coa2::kanMX4 oma1::CaURA3
W303 coa2:: kanMX4 cox15::CaURA3
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬, ura3-1
DY5113 COX10-3HA::TRP1
DY5113 COX10-13Myc::TRP1
DY5113 COX10-13Myc::TRP1 mss51::kanMX4
DY5113 COX10-13Myc::TRP1 cox14::CaURA3
DY5113, COX10-13Myc::TRP1, coa1::CaURA3
DY5113 COX10-13Myc::TRP1 shy1::CaURA3
DY5113 COX10-13Myc::TRP1 sco1::kanMX4
MAT␣ lys2 leu2-3,112 arg8::hisG ura3-52 cox1⌬::ARG8m COX10-13Myc::kanMX
DY5113 COX15-13Myc::TRP1
DY5113 SHY1-13Myc::TRP1
DY5113 SHY1-13Myc::TRP1 cox11::HIS3
DY5113 COA1-13Myc::HIS3
MATa arg8::hisG leu2-3,112 lys2 ura3-52 COX1-3HA D273-10B

with MSS51 in combination with either COX10 or COA2 in the
suppression of both coa1⌬ and shy1⌬ cells (29).
Coa2 is a small matrix-localized protein that functions downstream of the Mss51-dependent step in Cox1 maturation (29).
The observed transient interaction of Coa2 and Shy1 suggested
a role in the ShyI-related step in Cox1 maturation. One dramatic phenotype of coa2⌬ cells is the rapid degradation of
newly synthesized Cox1 (29). High-copy-number Mss51, which
efficiently suppresses the respiratory defect of coa1⌬ and shy1⌬
cells, had no effect in coa2⌬ cells, although high-copy-number
Cox10 was weakly effective. During these studies, we observed
spontaneous mutant clones of coa2⌬ cells with robust respiratory growth. In the present study we report the characterization of a mutant allele of COX10 that is a dominant suppressor
of coa2⌬ cells. We show that the suppressor activity of mutant
Cox10 is dependent on its catalytic activity and suggest that the
mutant Cox10 facilitates heme a addition into Cox1, a step that
is compromised in coa2⌬ cells. Coa2 per se is not essential for
hemylation of Cox1, since CcO biosynthesis can be restored in
coa2⌬ cells by depleting cells of the metallopeptidase Oma1.
The present work provides novel insight into the function of
Cox10, Coa2, and Oma1.
MATERIALS AND METHODS
Yeast strains and vectors. The Saccharomyces cerevisiae yeast strains used in
this study are listed in Table 1. The hemagglutinin (HA)-tagged Cox1 strain was
a generous gift from Xochitl Perez-Martinez. Strains with open reading frame
(ORF) deletions generated for this work were created by homologous recombination of disruption cassettes using either KanMX4 or Candida albicans URA3.

Source or
reference(s)

Invitrogen
29
Invitrogen
Invitrogen
Invitrogen
Invitrogen
29
25
23, 28
13
7
This work
29
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
29
This work
23, 28
X. Perez-Martinez

Strains with an integrated 3⬘-13Myc or 3⬘-3HA epitope tag were generated as
described previously (20). All strains generated for this work were confirmed by
PCR. The COX10 ORF was cloned into plasmid pRS426 and pRS416 under the
control of its own promoter and terminator (450 base pairs upstream and downstream of the ORF). The N196K mutation was made in both the high- and
low-copy-number vectors using site-directed mutagenesis. The COX10 ORF with
a 3⬘-13Myc tag was cloned from genomic DNA of the DY5113 COX10-13Myc
strain into pRS416 and pRS415 vectors under the control of its own promoter
and the ADH1 terminator. The N196K, N196A, N196D, R212,216A, and H317A
mutations were generated by site-directed mutagenesis. Successive rounds of
site-directed mutagenesis created the double and triple mutations. The COX15
ORF with a 3⬘-6His epitope tag was cloned into pRS423 under the control of the
MET25 promoter and CYC1 terminator. The YAH1 ORF was cloned into
pRS425 under the control of its own promoter (450 base pairs upstream of the
ORF) and the CYC1 terminator. Sequencing was used to confirm all cloning and
site-directed mutagenesis products in the vectors created. The MSS51, COA2,
and YTA12 (E614Q) vectors used have been previously described (29). Yeast
strains were transformed using lithium acetate. Culture conditions for the yeast
strains were either rich medium (YP) or synthetic complete (SC) medium lacking
the appropriate nutrients for plasmid selection.
Mitochondrial purification and assays. Intact mitochondria were isolated
from yeast as previously described (9). The standard Bradford assay was used to
determine total mitochondrial protein concentration (5). Total heme was extracted from 1 to 2 mg of purified mitochondria with 0.5 ml acetone containing
2.5% HCl as described previously (4). The pH of the extract was adjusted to 4.0
by the addition of 1 l formic acid and titration with 5 M KOH (elution times are
affected by the pH). The sample was clarified by centrifugation at 13,000 rpm for
5 min, and 1 ml was injected onto a 4.6- by 250-mm SunFire C18 5-m column
(Waters). Hemes were eluted from the column at a flow rate of 1 ml/min using
a 30 to 50% gradient of acetonitrile containing 0.05% trifluoroacetic acid for the
first 3 ml and a 50 to 80% gradient for the next 42 ml. The elution of heme
compounds was monitored at 400 nm; purified heme a, heme o, and hemin were
used as standards to determine elution times. Heme a was a generous gift from
Winslow Caughey.
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Blue native PAGE. Blue native PAGE (BN-PAGE) was performed essentially
as described previously (38) with 1% digitonin. After incubation on ice for 15 min
and centrifugation (20,000 ⫻ g for 15 min at 2°C), supernatants were mixed with
sample buffer (5% Coomassie brilliant blue G250, 0.5 M 6-aminocaproic acid,
pH 7.0) and then loaded on a gradient polyacrylamide gel. Separated complexes
were detected by immunoblotting on a polyvinylidene difluoride (PVDF) membrane. The high-mass marker proteins were obtained from GE Healthcare.
Immunoblotting. Mitochondrial protein samples were separated on 12% polyacrylamide gels and transferred to nitrocellulose. Proteins were visualized using
either enhanced chemiluminescence (ECL) reagents with horseradish peroxidase-conjugated secondary antibodies or the Odyssey infrared imaging system
(Li-Cor Biosciences) with fluorescent secondary antibodies (anti-mouse IRDye
800 and anti-rabbit IRDye 680; Li-Cor Biosciences). Anti-Myc and anti-HA
rabbit polyclonal antisera was purchased from Santa Cruz, anti-Myc and anti-HA
mouse monoclonal antibodies were from Roche, antiporin was from Molecular
Probes, and anti-Cox2 was from Mitosciences. Alex Tzagoloff generously provided antiserum to F1 ATP synthase, and Thomas Langer provided antisera to
Phb1 and Phb2.
IP. Immunoprecipitations (IPs) were performed essentially as described previously (29) except that the IP buffer used was 20 mM Tris (pH 7.4), 50 mM
sodium chloride, 1 mM phenylmethylsulfonyl fluoride, and 1% digitonin. AntiHA–agarose and anti-Myc–agarose conjugates were purchased from Santa Cruz.
The clarified lysate, unbound, final wash, and elution fractions were analyzed by
immunoblotting.
Additional assays. The respiratory competency of strains was determined by
growth tests on plates containing 2% glucose or 2% glycerol–2% lactate as a
carbon source. Yeast cells were grown overnight in liquid cultures in selective
medium containing 2% raffinose–0.2% glucose and adjusted to an optical density
at 600 nm (OD600) of 0.5, and serial dilutions were spotted onto the plates and
incubated at 30°C for 2 days (glucose plates) or 4 to 6 days (glycerol-lactate
plates). The oxygen consumption of cells grown to stationary phase was determined on a 5300A biological oxygen monitor (Yellow Springs Instrument Co.).
The rate of oxygen consumption (% O2/second/OD600 unit) was calculated from
the linear response (17). For in vivo mitochondrial labeling with [35S]methionine,
cells were grown overnight in selective medium containing 2% raffinose–0.2%
glucose and then reinoculated into YP–2% galactose to grow to an OD600 of 1.
The labeling and preparation of the samples for 12% SDS-PAGE have been
described previously (2). Gels were dried, and radiolabeled proteins were visualized by exposing autoradiographic films at ⫺80°C. Sensitivity of yeast strains to
hydrogen peroxide was determined as previously described (19).
Construction of the low-copy-number library. Genomic DNA purified from
the coa2⌬ suppressor strain containing the COX10-N196K mutation was partially
digested with Sau3A. DNA fragments were then purified from an agarose gel and
ligated with plasmid pRS416 that was digested to completion with BamHI. The
resulting number of transformants was sufficient for severalfold coverage of the
yeast genome.

RESULTS
Isolation of a coa2⌬ dominant suppressor. Coa2 is required
for the assembly of CcO in yeast (29). Cells lacking Coa2 fail
to propagate on glycerol/lactate growth medium (29) (Fig. 1A).
With prolonged incubation on glycerol/lactate medium, spontaneous mutants emerged that showed robust growth upon
subsequent replating. The frequencies of appearance of spontaneous mutants were 1 in 107 colonies for coa2⌬ cells in the
BY4741 background and 1.7 in 106 colonies for coa2⌬ cells in
the W303 background. Recovery of one spontaneous suppressor clone showed that upon subsequent plating, respiratory
growth resembled that of wild-type (WT) cells (Fig. 1A). coa2⌬
null cells exhibit a marked attenuation of newly synthesized
Cox1 in an in vivo translation assay, and this attenuation was
shown to arise from enhanced degradation rather than impaired translation (29). The suppressor mutant showed normal
Cox1 levels in the in vivo translation assay (Fig. 1B). To assess
whether the suppressing mutation was recessive or dominant,
the suppressor isolate was crossed with the parent coa2⌬ strain
of opposite mating type. The resulting diploid strain was found
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to be respiration competent in showing WT growth on glycerol/
lactate medium. The diploid was sporulated, and tetrad dissection revealed that the suppressing phenotype segregated 2:2,
suggesting that a single mutant gene was responsible for the
phenotype.
To clone the dominant mutant gene, a genomic library was
constructed from the genomic DNA of the suppressor coa2⌬
clone in a centromeric vector. Recombinant plasmid DNA was
used to transform coa2⌬ parent cells, and transformants that
grew on glycerol/lactate medium were isolated. The respiratory
growth was shown to be dependent on the library vector, as
shedding the vector by growth in 5-fluorortate abrogated respiratory growth. The plasmid rescued from the respirationcompetent coa2⌬ cells was used to retransform coa2⌬ cells,
and respiratory competence was recovered. DNA sequencing
revealed the suppressor gene to be a mutated COX10 causing
an N196K amino acid change. Asn196 is a highly conserved
residue in diverse Cox10 orthologs (Fig. 1C).
The N196K mutation was introduced in a low-copy-number
plasmid containing COX10 and transformed into coa2⌬ or
cox10⌬ cells (Fig. 1D). The mutant Cox10 restored respiratory
growth in coa2⌬ cells, demonstrating that the mutation was
sufficient to confer the suppressor phenotype. WT COX10 is
only a weak suppressor in coa2⌬ cells when expressed in high
copy number, a situation similar to its weak suppressor activity
in coa1⌬ cells (28, 29). The observed respiratory growth of
cox10⌬ cells harboring the N196K mutant allele showed that
the substitution did not impair the catalytic activity of Cox10.
This conclusion was substantiated by the observation that oxygen consumption by cox10⌬ cells containing either WT Cox10
or the N196K mutant protein was similar (Fig. 1E). No dominant negative effects were observed in transformants of WT
cells with the mutant Cox10 regardless of whether it was expressed from a low- or high-copy-number vector.
The presence of the mutant Cox10 in coa2⌬ cells restored
Cox1 levels in the in vivo mitochondrial translation assay (Fig.
1F) better than the WT Cox10 protein. Likewise, mutant
Cox10 restored Cox1 levels in cox10⌬ cells.
N196K Cox10 is a coa2⌬-specific suppressor. N196K Cox10
has a gain-of-function activity in coa2⌬ cells. To substantiate
this activity, we engineered the mutation in a cox10 allele
encoding a double substitution of two functionally important
conserved Arg residues implicated in the binding of the pyrophosphate moiety of the farnesyl pyrophosphate substrate of
the Cox10-related CyoE heme o synthase of Escherichia coli
(31). The double-Arg Cox10 mutant (R212,216A) was nonfunctional in cox10⌬ cells (Fig. 1D) and failed to suppress
either coa1⌬ cells (28) or coa2⌬ cells despite the presence of
the mutant protein by immunoblotting (data not shown). However, the triple mutant (N196K, R212,216A) retained the suppressor activity in coa2⌬ cells and, surprisingly, restored Cox10
function in cox10⌬ cells (Fig. 1D and E). Thus, the N196K
substitution has a dominant effect on the Cox10 suppressor
activity.
We previously demonstrated that high-copy-number COX10
was a weak suppressor of coa1⌬ and shy1⌬ cells (28). To assess
whether the N196K mutant Cox10 exhibited gain-of-function
suppressor activity in these cells, low- and high-copy-number
vectors carrying either WT or mutant COX10 were transformed in coa1⌬ and shy1⌬ cells, and respiratory growth was
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FIG. 1. Identification of the coa2⌬ suppressor mutant as N196K Cox10. (A) W303 wild type (WT), coa2⌬, and isolated coa2⌬ suppressor strains
were grown in yeast extract-peptone-dextrose, serially diluted, and spotted on yeast extract–peptone–2% glucose and yeast extract–peptone–2%
glycerol-2% lactate. Plates were grown at 30°C. (B) In vivo labeling of mitochondrial translation products. The strains described for panel A were
pulsed with [35S]methionine for 5, 12, and 25 min at 30°C. The samples were separated by 12% SDS-PAGE, and the gel was dried and then exposed
to autoradiographic film. (C) Alignment of the peptide sequences of Cox10 from various species using ClustalW. The box highlights the conserved
N196 residue. Arg212 and Arg216, residues required for activity, are underlined. Residues with conserved substitutions across species are indicated
by colons, and identical residues across species are indicated by asterisks. (D) BY cox10⌬, coa2⌬, and wild-type cells transformed with centromeric
vectors expressing WT Cox10, N196K Cox10, R212A,R216A Cox10, and N196K,R212A,R216A Cox10 (Triple) were grown in SC–2% raffinose–
0.2% glucose selective medium, serially diluted, and spotted on SC–2% glucose and SC–2% glycerol–2% lactate. The plates were incubated at
30°C. Similar results were observed for cells transformed with episomal vectors. (E) The cells described for panel D were grown in liquid SC–1%
glucose overnight, and oxygen consumption (% O2/second/OD600 unit) was measured. The data represent the averages of four independent
repeats, and the error bars represent standard errors of the means. (F) In vivo labeling of mitochondrial translation products. W303 cox10⌬ cells
(lanes 1 to 6) and W303 coa2⌬ cells (lanes 7 to 12) transformed with episomal vectors expressing WT Cox10 and N196K Cox10 were pulsed with
[35S]methionine for 5 and 25 min. The samples were analyzed as described for panel B.

176

BESTWICK ET AL.

FIG. 2. N196K Cox10 does not alter suppression of the respiratory
defect of coa1⌬ or shy1⌬ cells. (A) BY coa1⌬ cells transformed with
either episomal (YEp) or centromeric (YCp) vectors expressing WT
COX10 or COX10 (N196K) were grown in SC–2% raffinose–0.2%
glucose selective medium, serially diluted, and spotted on SC–2%
glucose and SC–2% glycerol–2% lactate agar plates. The plates were
incubated at 30°C. (B) BY shy1⌬ cells with either YEp or YCp vectors
expressing WT COX10 or COX10 (N196K) were treated as described
for panel A.

assessed (Fig. 2). The WT and mutant genes were equally weak
suppressors in these CcO assembly mutants. In addition, no
suppression by the N196K Cox10 was seen in cox14⌬ cells
(data not shown). Thus, the N196K Cox10 has a unique suppressor function in coa2⌬ cells.
The N196K mutant Cox10 may exert its specific suppressor
function in coa2⌬ cells by one of two mechanisms. The first
scenario is that the mutant Cox10 has a gain-of-function role in
directly stabilizing newly synthesized Cox1, thereby impairing
proteolytic degradation. The second candidate mechanism is
that mutant Cox10 has an enhanced efficiency in heme a site
formation in Cox1. The marked instability of Cox1 seen in
coa2⌬ cells may arise from an impaired addition of heme a,
since the heme a site stabilizes the Cox1 helical bundle. Studies
were conducted to discern between these candidate mechanisms of suppression.
N196K Cox10 has no general role in the stabilization of
Cox1. The first postulate is that the N196K mutant Cox10 has
a gain-of-function role in stabilizing Cox1 within early assembly intermediates. One marked phenotype of coa2⌬ cells is the
rapid degradation of Cox1 observed with in vivo mitochondrial
translation assays (29) (Fig. 1F). We conducted three studies to
test this first postulate. First, Coa1 and Shy1 participate in
early Cox1 assembly intermediates downstream of the Mss51Cox14 complex and have previously been shown to bind Cox1
(23, 28). To assess whether N196K mutant Cox10 had an effect
on the abundance of these Cox1 assembly complexes, mitochondria isolated from cells chromosomally epitope tagged at
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the COA1 and SHY1 loci were fractionated on BN-PAGE (Fig.
3A). The presence of N196K Cox10 had no effect on the
abundance of Cox1-containing high-mass Coa1 and Shy1 complexes. The high-mass Shy1 complex is attenuated in numerous
CcO assembly mutants, such as cox11⌬ cells (Fig. 3A, lane 8).
The N196K mutant Cox10 had no stabilizing effect on the
Cox1-containing ⬃450-kDa Shy1 complex in these cells (Fig. 3,
lane 9). Second, the N196K mutant Cox10 fails to stabilize
Cox1 in two CcO assembly mutants (coa1⌬ and cox4⌬ cells) in
which newly synthesized Cox1 is proteolytically unstable (Fig.
3B). Cox1 is synthesized in coa1⌬ and cox4⌬ cells as seen in an
in vivo mitochondrial translation assay, but it is degraded during the chase phase of the assay. The presence of either WT
Cox10 or the N196K mutant failed to retard Cox1 degradation
in either mutant strain. Third, mutant Cox10 lacks any Cox1
stabilization function as determined using a hydrogen peroxide
sensitivity assay. Cells lacking Cox11 are sensitive to hydrogen
peroxide due to the accumulation of a stalled heme a3-Cox1
assembly intermediate (19). We reported previously that overexpression of either COX10 or COA2 exacerbated the sensitivity of cox11⌬ cells to peroxide, most likely through stabilizing the heme a3-Cox1 assembly intermediate (29). The N196K
mutant Cox10 did not induce any further peroxide hypersensitivity to cox11⌬ cells relative to WT Cox10 (Fig. 3C). These
three studies argue against mutant Cox10 having any general
Cox1 stabilization function and further support the specific
suppression of coa2⌬ cells.
Suppressor activity of N196K Cox10 is dependent on its
catalytic activity. The second candidate mechanism of suppression by the N196K mutant Cox10 is related to its role in heme
a biosynthesis. Suppression of coa2⌬ cells by the mutant Cox10
may arise from more efficient hemylation of Cox1. If Coa2
functions at a point in which the heme a site is formed, the
absence of Coa2 may destabilize the heme a site occupancy,
leading to an altered Cox1 conformation that is susceptible to
proteolytic degradation. To test whether N196K Cox10 had
enhanced catalytic activity, we evaluated whether strains harboring the mutant had elevated levels of heme o (Fig. 4A). The
mutant and WT Cox10 proteins were expressed in either
cox10⌬ or coa2⌬ cells. Mitochondria purified from each transformant were quantified for various hemes using reverse-phase
high-pressure liquid chromatography (HPLC) after organic extraction (Fig. 4A, inset). Comparable levels of heme a were
evident in cox10⌬ cells containing either the WT or the N196K
Cox10 mutant (80 and 85% of WT level, respectively), but no
heme o was evident in either extraction. The detection limit for
heme o in our assay is 10% of heme a levels. Likewise, coa2⌬
cells harboring either the WT or the N196K Cox10 mutant had
no detectable levels of heme o.
His317 of Cox10 is a highly conserved residue and is implicated in catalytic activity (24). To test whether the suppressor
activity of the N196K Cox10 mutant was dependent on the
catalytic activity of the enzyme, an H317A substitution was
engineered in WT and N196K Cox10 and the resulting mutants
were tested for function in cox10⌬ cells or suppressor activity
in coa2⌬ cells (Fig. 4B). The H317A Cox10 mutant failed to
support respiratory growth when expressed in cox10⌬ cells, as
was true with the double H317A,N196K mutant. Immunoblotting revealed that the single H317A mutant was unstable when
expressed in cox10⌬ cells, but the double H317A,N196K mu-
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tant was stably expressed (Fig. 4C). In addition to the respiratory deficiency of cox10⌬ transformants with the double
H317A,N196K mutant, steady-state levels of Cox2 were also
attenuated as seen in the parent cox10⌬ cells (Fig. 4C). Expression of the mutants in coa2⌬ cells revealed that the
H317A,N196K double mutant failed to suppress the respiratory deficiency of coa2⌬ cells. Whereas expression of the
N196K mutant Cox10 in coa2⌬ cells resulted in stable Cox1
levels seen in the mitochondrial translation assay, expression of
the H317A,N196K double mutant showed a rapid degradation
of Cox1 similar to that seen in untransformed coa2⌬ cells (Fig.
4D). To corroborate the evidence that heme a biosynthesis was
essential for the suppressor activity of the N196K mutant
Cox10, we tested whether the N196K mutant Cox10 retained
suppressor activity in stabilizing Cox1 in the mitochondrial
translation assay in cells lacking Cox15, the second enzyme
required in heme a biosynthesis. The N196K mutant Cox10
was expressed in coa2⌬ cox15⌬ cells (Fig. 4E). In the mitochondrial translation assay, no Cox1 was observed during the
pulse despite the presence of the N196K Cox10. Thus, the
catalytic activity of Cox10 and the synthesis of heme a are
essential for the suppression of respiratory function and Cox1
stabilization in coa2⌬ cells.
We addressed the specificity of the Asn196 substitution for
the gain-of-function suppressor activity in coa2⌬ cells. Two
mutations were introduced into COX10, yielding N196A and
N196D substitutions, and these mutants were expressed in
cox10⌬ or coa2⌬ cells (Fig. 4B). None of the substitutions at
Asn196 altered the function of Cox10, since all cox10⌬ transformants grew well on glycerol/lactate medium. However, the
N196D mutant Cox10 lacked suppressor activity in coa2⌬ cells,
and the N196A Cox10 yielded only partial restoration of respiratory growth. Thus, the charge at position 196 appears to
be important for suppressor activity. The glycerol/lactate
growth results matched the stabilization of Cox1 in the mitochondrial translation assay (Fig. 4D).
Suppressor activity of N196K Cox10 correlates with the
abundance of its high-mass complex. The N196K Cox10 was
reproducibly more abundant relative to the WT protein when
expressed in cox10⌬ and coa2⌬ cells (Fig. 4C) or WT cells

FIG. 3. Stabilization of Cox1 by N196K Cox10 is specific to coa2⌬
cells. (A) Mitochondria (50 g protein) isolated from strains containing a genomically tagged 13-Myc COA1 gene (lanes 1 to 3) or SHY1

gene (lanes 4 to 6) and expressing either WT Cox10 or N196K Cox10
were solubilized in buffer containing 1% digitonin. Lysates were
loaded onto a continuous 5 to 13% gradient gel, and protein complexes
were separated by BN-PAGE. Complexes were analyzed by immunoblotting with anti-Myc antibody. Molecular mass markers are indicated, and antibody to the F1␤ subunit of monomeric complex V was
used as a loading control. Mitochondria (50 g protein) isolated from
WT, cox11⌬, or cox11⌬ cells expressing N196K Cox10 and containing
an endogenously tagged SHY1-13Myc (lanes 7 to 9) were solubilized,
separated by BN-PAGE, and analyzed by immunoblotting as in the
first two panels. (B) In vivo labeling of mitochondrial translation products. W303 WT, coa1⌬, and cox4⌬ cells transformed with WT Cox10 or
N196K Cox10 were used in the translation assay as described for Fig.
1B. (C) cox11⌬ cells transformed with YCp Cox10 or YCp N196K
Cox10 vectors and W303 WT cells were grown to mid-exponential
phase and incubated with (⫹) or without (⫺) the indicated concentrations of H2O2 for 2 h at 30°C. Serial dilutions were spotted onto
yeast extract-peptone-dextrose plates and incubated for 36 to 48 h at
30°C. Similar results were obtained for YEp COX10 and N196K
COX10 in the cox11⌬ background.
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FIG. 4. Catalytically active Cox10 and heme a generation are required for suppressor activity by N196K Cox10. (A) Heme was extracted from
mitochondria (1.5 to 2 mg protein) isolated from WT cells, cox10⌬ cells expressing YCp WT Cox10 or N196K Cox10, and coa2⌬ cells expressing
YCp WT Cox10 or Cox10-N196K and separated by reverse-phase high-performance liquid chromatography. The inset shows a representative
chromatogram from WT mitochondria. The peaks corresponding to heme b (B), heme a (A), and protoporphyrin (P) and the expected elution time
of heme o (O) are indicated. The white bars indicate the area under the heme b peak normalized to mg of mitochondrial protein, and the black
bars represent the area under the heme a peak also normalized to mg of mitochondrial protein. The data represents the averages of three
independent repeats, and the error bars represent the standard errors of the means. ND, not detectable. (B) cox10⌬ and coa2⌬ cells expressing
WT Cox10, N196K Cox10, H317A Cox10, N196K-H317A Cox10, N196A Cox10, and N196D Cox10 were grown in SC–2% raffinose–0.2% glucose
selective medium, serially diluted, and drop tested on SC–2% glucose or yeast extract–peptone–2% glycerol-2% lactate. The plates were incubated
at 30°C for 2 days (glucose) or 4 days (glycerol/lactate). (C) Purified mitochondria (30 g protein) from cox10⌬ and coa2⌬ cells expressing WT
Cox10-13Myc, N196K Cox10-13Myc, H317A Cox10-13Myc, and N196K-H317A Cox10-13Myc were separated by SDS-PAGE and analyzed by
immunoblotting using anti-Myc, anti-Cox2, and anti-Por1 (loading control) antibodies. (D) In vivo mitochondrial translation. W303 coa2⌬ cells
expressing WT Cox10, N196K Cox10, H317A Cox10, N196K-H317A Cox10, N196A Cox10, and N196D Cox10 were pulsed with [35S]methionine
as for Fig. 1B. (E) Analysis of mitochondrial translation products in W303 coa2⌬ cox15⌬ cells expressing COA2, COX15, WT COX10, and COX10
(N196K). The cells were pulsed with [35S]methionine for 20 min at 30°C and analyzed as for Fig. 1B.

(data not shown). To gain further insights into Cox10 function,
we carried out BN-PAGE on Myc-tagged Cox10 (Fig. 5A).
Cox10 forms a high-mass complex when expressed either from
a vector or chromosomally (Fig. 5A, lanes 2 and 7). Surprisingly, the N196K mutant protein forms a markedly more abundant high-mass complex than the WT protein (Fig. 5A, lanes 3
and 6). The presence of the untagged N196K mutant Cox10 in
WT cells containing a chromosomally tagged COX10 also

yields a marked enhancement in the abundance of the highmass complex (Fig. 5A, lanes 8 and 9). Importantly, the highmass Cox10 complex is gone in coa2⌬ cells (Fig. 5A, lane 5)
despite the presence of the protein seen by SDS-PAGE (Fig.
4C). The N196K mutant protein forms an abundant complex in
coa2⌬ cells (Fig. 5A, lane 6). BN analyses were carried out on
mutant Cox10 alleles with various Asn196 substitutions. The
N196D mutant, which lacked suppressor activity (Fig. 4B), also
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lacked any appreciable BN complex (Fig. 5B, lane 4), although
the protein was equally present as determined by steady-state
SDS-PAGE analysis. The N196A mutant, which had limited
suppressor activity, formed a high-mass complex that was less
abundant than the N196K mutant protein. Thus, a correlation
exists between the abundance of the Cox10 complex and its
suppressor activity. The N196D and N196A mutant proteins
formed a high-mass complex of similar abundance when expressed in cox10⌬ cells (Fig. 5B, lanes 7 and 8).
As mentioned, the H317A mutation in Cox10 abrogates any
suppressor activity of the N196K allele. However, the inactive
N196K,H317A mutant Cox10 still forms a low-abundance
complex in both coa2⌬ and cox10⌬ cells (Fig. 5C). Thus, formation of the high-mass Cox10 complex is not dependent on a
catalytically active enzyme.
The enhanced Cox10 BN complex seen in chromosomally
tagged Cox10 cells expressing a low-copy-number untagged
N196K Cox10 from a vector suggests that the ⬃370-kDa complex may be a Cox10 oligomer. Two additional studies corroborate the existence of a homo-oligomer complex. First, cells
expressing chromosomally HA-tagged Cox10 and vector Myctagged Cox10 were tested for co-IP (Fig. 5D). Precipitation of
HA-Cox10 resulted in co-IP of a fraction of Myc-Cox10, especially in the cells with the N196K Cox10. Second, coexpression
of the unstable H317A Cox10 mutant (Fig. 4C) with the
N196K mutant led to a pronounced stabilization of the unstable H317A Cox10 in either coa2⌬ or cox10⌬ cells (Fig. 5E).
The cotransformants of both strains were fully competent in
growth on glycerol/lactate medium (data not shown). The stabilized H317A Cox10 did not have any dominant negative
effects.
We sought to assess whether other components were present
in the high-mass Cox10 complex by taking a candidate protein
approach. Three candidates are Coa2, Cox15, and Cox1. No
stable interaction between Coa2 and Cox10 was observed in
co-IP studies. Cox10 functions in heme a biosynthesis together
with Cox15. Since bacterial Cox10 and Cox15 orthologs were
reported to associate within a complex (6), we tested whether

FIG. 5. Assessing the Cox10 high-molecular-weight complex.
(A) Purified mitochondria (100 g protein) from cox10⌬ and coa2⌬
cells expressing WT Cox10-13Myc and N196K Cox10-13Myc (lanes 1
to 6) were solubilized in buffer containing 1% digitonin. Lysates were
loaded onto a 5 to 13% gradient gel, and complexes were separated by
BN-PAGE. Lanes 7 to 9 show the BN-PAGE analysis of mitochondria
(100 g protein) isolated from a genomically tagged COX10-13Myc
strain expressing WT Cox10 or N196K Cox10 (both untagged). The
Cox10-13Myc complex was detected by immunoblotting using antiMyc antibody in all panels, and monomeric complex V was detected
using anti-F1␤ antibody as a loading control. (B) Purified mitochondria (100 g proteins) from both coa2⌬ and cox10⌬ cells expressing
N196K Cox10-13Myc, N196A Cox10-13Myc, and N196D Cox1013Myc were analyzed by BN-PAGE as described for panel A. (C) Isolated mitochondria from cox10⌬ cells expressing WT Cox10-13Myc,

H317A Cox10-13Myc, and H317A,N196K Cox10-13Myc (HA,NK13Myc), and from coa2⌬ cells expressing H317A Cox10-13Myc and
HA,NK-13Myc were analyzed by BN-PAGE as described for panel A.
(D) Purified mitochondria (500 g protein) from endogenously tagged
COX10-3HA cells, COX10-3HA cells expressing WT Cox10-13Myc or
N196K Cox10-13Myc, and endogenously tagged COX10-13Myc cells
were solubilized in IP buffer, and clarified extracts were immunoprecipitated with rabbit polyclonal anti-HA beads overnight. The fractions
for each co-IP were analyzed by SDS-PAGE and immunoblotting
using anti-Myc and anti-HA antibodies. Load, 2% of the soluble extract; unbound, 2% of the soluble extract after incubation with the
HA-conjugated beads; wash, 50% of the last wash concentrated by
trichloroacetic acid precipitation; and elution, 50% of the bead elution.
IP using mouse monoclonal Myc-conjugated beads provided similar
results. (E) Mitochondria (30 g protein) purified from coa2⌬ cells
expressing either WT Cox10-13Myc or H317A Cox10-13Myc and these
two plasmids expressed in trans with untagged N196K Cox10 were
analyzed for steady-state levels of Cox10 by SDS-PAGE and immunoblotting using anti-Myc antibody and Por1 as a loading control. Similarly, mitochondria (30 g protein) purified from cox10⌬ cells expressing H317A Cox10-13Myc in trans with untagged WT Cox10 or N196K
Cox10 was analyzed as described.
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FIG. 6. Cox10 and Cox15 form distinct high-molecular-weight
complexes. (A) Mitochondria (100 g protein) isolated from WT or
cox15⌬ cells containing an endogenously tagged 13-Myc COX10 gene
were solubilized in buffer containing 1.5% digitonin. The lysates were
run on a continuous 5 to 13% gradient gel, and protein complexes were
separated by BN-PAGE. The Cox10-13Myc complex was detected by
immunoblotting with anti-Myc antibody. Molecular mass markers are
indicated. (B) Purified mitochondria from cells containing either a
genomically tagged 13-Myc COX10 gene or 13-Myc COX15 gene were
solubilized (100 g and 30 g mitochondrial protein, respectively) and
analyzed by BN-PAGE as described for panel A. (C) Mitochondria (35
g protein) isolated from strains containing a genomically tagged
13-Myc COX15 gene expressing either WT Cox10 or Cox10-N196K
were solubilized and analyzed by BN-PAGE as described for panel A.
The Cox10-13Myc and Cox15-13Myc complexes were detected by immunoblotting with anti-Myc antibody. (D) coa2⌬ cells transformed
with COA2, YEp COX15, and/or YEp YAH1 were grown in SC–2%
raffinose–0.2% glucose selective medium, serially diluted, and drop
tested on SC–2% glucose and SC–2% glycerol–2% lactate. Plates were
at 30°C for 2 days (glucose) or 5 days (glycerol/lactate).

the Cox10 complex was abrogated in cells lacking Cox15 (Fig.
6A). COX15 was deleted in cells chromosomally tagged at the
COX10 locus. The Cox10 BN complex persisted in cox15⌬
cells, suggesting that Cox15 is not a stable component of the
high-mass Cox10 complex. This conclusion is substantiated by
the observation that Cox10 and Cox15 form distinct high-mass
complexes on BN-PAGE that migrate at different sizes (Fig.
6B). The N196K Cox10 mutant had no effect on the abundance
of the high-mass Cox15 BN complex (Fig. 6C), suggesting that
the mutant Cox10 has a specific enhancement effect on the
Cox10 BN complex.
Cells stalled in CcO biogenesis show limited levels of heme
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o. Overexpression of COX15 along with the YAH1 ferredoxin
was shown to elevate heme a levels by greater than 50-fold (4).
To assess whether high heme a levels were sufficient to suppress the respiratory deficiency of coa2⌬ cells, mutant cells
containing both genes on high-copy-number vectors were
tested for growth on glycerol/lactate (Fig. 6D). Elevated levels
of both proteins failed to impart respiratory growth. Thus, the
robust suppressor activity of N196K Cox10 relates to a function
of Cox10 in addition to its catalytic role in heme o formation.
The high-mass complexes of Mss51, Coa1, and Shy1 contain
Cox1, so Cox1 is a third candidate component of the ⬃370kDa Cox10 complex. Although no general Cox1 stabilization
effect was observed with the N196K mutant Cox10, Cox10 may
interact with Cox1 during the insertion of heme a. The lack of
the high-mass Cox10 complex in coa2⌬ cells may arise from
Cox1 degradation. We tested whether the high-mass Cox10
complex was restored in coa2⌬ cells overexpressing Mss51 to
stimulate Cox1 translation. As can be seen in Fig. 7A (lane 3),
elevated levels of Mss51 partially restored steady-state levels of
the high-mass Cox10 BN complex. This result implies a link
between Cox1 and the Cox10 complex. To test the involvement
of early Cox1 assembly intermediates in the oligomeric Cox10
complex, cells containing chromosomally Myc-tagged COX10
were used to construct deletions in MSS51, COX14, COA1,
SHY1, or SCO1. The Cox10 BN complex was abrogated in all
mutant strains other than sco1⌬ cells (Fig. 7B). Cells lacking
Mss51 fail to translate full-length Cox1, but cells lacking either
Cox14 or Coa1 synthesize Cox1; however, the protein is unstable (28). The oligomeric Cox10 complex is largely attenuated in cox1⌬ cells, but a residual complex persists. To assess
whether the oligomeric complex of N196K mutant Cox10 is
dependent on Cox1, WT and mutant Cox10 were expressed in
cells lacking Mss51, Cox14, or Coa1 (Fig. 7C). Whereas neither
form of Cox10 was competent to form stable oligomeric complexes in mss51⌬ and cox14⌬ cells, the oligomeric N196K mutant Cox10 complex was seen in coa1⌬ cells. Levels of newly
synthesized Cox1 are comparable in cox14⌬ and coa1⌬ cells,
yet Cox10 is responsive to Cox1 levels only in coa1⌬ cells. No
direct stable interaction of Cox10 and Cox1 is observed. HAtagged Cox1 did not co-IP with Myc-tagged Cox10 (Fig. 7D),
and two-dimensional BN-PAGE failed to show comigration of
Cox10 and Cox1 (data not shown). Although a co-IP of Cox10
and Cox1 was not observed, we did reproduce the known
interactions of Coa1 with Cox1 and of Shyl with Cox1 (data
not shown). Thus, formation of the high-mass Cox10 complex
is linked to Cox1 translation and formation of the Mss51/
Cox14-containing Cox1 complex, although no direct interaction between Cox10 and Cox1 exists that is stable to co-IP.
An unbiased proteomic approach was taken to identify components in the high-mass Cox10 BN complex. Digitonin-solubilized mitochondrial supernatant isolated from chromosomally tagged Cox10 cells was used for immunoprecipitation (IP)
by anti-Myc agarose beads. Resolution of the IP on SDSPAGE followed by mass spectrometry of the silver-stained
bands revealed Cox10 and prohibitin subunits (Phb1 and
Phb2) and the mAAA subunits (Yta10 and Yta12). Cox1 was
not observed. The prohibitin and mAAA components are apparently nonspecific IP products, as prohibitin subunits also
were recovered with control beads and mAAA associates with
the prohibitin complex (33).

FIG. 7. Cox1 is not a stable component of the Cox10 high-molecular-weight complex. (A) Isolated mitochondria (100 g protein) from WT, coa2⌬,
and coa2⌬ cells expressing YEp MSS51 containing an endogenously tagged 13-Myc COX10 gene were solubilized and analyzed by BN-PAGE as
described previously. Detection of the F1␤ subunit of monomeric complex V was used as a loading control. The lower panel represents purified
mitochondria (30 g protein) from the same strains analyzed under denaturing (SDS-PAGE) conditions. Anti-Myc antibody was used to detect
Cox10-13Myc, and Por1 was used as a loading control. (B) Mitochondria purified from WT, mss51⌬, cox14⌬, coa1⌬, shy1⌬, coa2⌬, sco1⌬, and cox1⌬
strains containing chromosomally tagged COX10-13Myc were analyzed by both native (BN, 100 g mitochondrial protein) and denaturing (SDS, 30 g
mitochondrial protein) PAGE using anti-Myc antibody. (C) Mitochondria (100 g protein) from chromosomally tagged COX10-13Myc strains with
mss51⌬ (lanes 1 and 2), cox14⌬ (lanes 4 and 5), or coa1⌬ (lanes 7 and 8) expressing WT Cox10 or mutant N196K Cox10 were analyzed by BN-PAGE
and SDS-PAGE as described previously. (D) Cox1 and Cox10 do not have a stable interaction. Mitochondria (350 g protein) from COX1-3HA cells,
COX1-3HA cells expressing YCp WT Cox10, or Cox10-N196K and COX10-13Myc cells were solubilized in IP buffer, and clarified extracts were
immunoprecipitated with rabbit polyclonal anti-HA beads. All co-IP samples were analyzed by SDS-PAGE and immunoblotting as indicated. Details are
as described for Fig. 6B. The asterisk indicates the rabbit immunoglobulin G heavy chain detected with the secondary antibody used in the analysis.
Similar co-IP results were obtained using mouse monoclonal Myc-conjugated beads.
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Cox1 degradation in coa2⌬ cells by the Oma1 metallopeptidase. One dramatic effect of the N196K Cox10 mutant is the
abrogation of the facile degradation of Cox1 in coa2⌬ cells.
The final question addressed is whether full respiratory activity
could be restored in coa2⌬ cells if Cox1 degradation was impaired. The mAAA is the most obvious candidate IM protease,
although our previous studies with coa2⌬ cells containing a
compromised mAAA protease showed only weak respiratory
growth (29). Two other protease systems besides mAAA reside
within the mitochondrial IM, iAAA (Yme1) and Oma1 (Fig.
8D). The iAAA has its catalytic activity facing the intermembrane space (IMS) side of the IM and has a role in Cox2
degradation (14, 15). Oma1 is a conserved metallopeptidase
that functions with the mAAA protease in the degradation of
misfolded polytopic IM proteins (18). To assess whether the
other IM-associated proteases contribute to the rapid Cox1
degradation seen in coa2⌬ cells, we constructed double-deletion strains in which OMA1 or YME1 was disrupted in the
coa2⌬ background (Fig. 8A). The absence of Yme1 failed to
markedly enhance respiratory growth of coa2⌬ cells, but robust
respiratory growth was achieved by the deletion of OMA1.
Respiratory activity as measured by oxygen consumption was
restored to ⬃50% of the WT level in coa2⌬ oma1⌬ cells (Fig.
8B), and Cox1 protein levels were restored in the in vivo mitochondrial translation assay (data not shown). The high-mass
BN Cox10 complex was also restored in the double-null cells
(Fig. 8C). Thus, respiratory function can be restored in coa2⌬
cells either by the suppressor activity of mutant Cox10 or by
selectively impaired proteolysis. A modest synergism exists between the two mechanisms. Respiratory growth of coa2⌬
oma1⌬ cells is enhanced by the expression of the N196K mutant Cox10 (data not shown).
DISCUSSION
Cells lacking Coa2 are stalled in CcO biogenesis and exhibit
a rapid degradation of newly synthesized Cox1, leading to
impaired CcO biogenesis. The respiratory deficiency of coa2⌬
cells is suppressed either by the presence of a mutant allele of
the Cox10 farnesyl transferase or by impairing proteolysis of
newly synthesized Cox1 through the disruption of the Oma1
IM protease. The N196K mutant Cox10 is a gain-of-function
and specific suppressor of coa2⌬ cells. Whereas high-copynumber WT Cox10 has limited suppressor activity in restoring
respiratory growth to coa1⌬ and shy1⌬ cells, the mutant Cox10
was no more effective than the WT protein in those CcO
assembly mutants. The N196K substitution did not attenuate
Cox10 catalytic activity, since the mutant protein was fully
functional when expressed in cox10⌬ cells. The mutant Cox10
restores near-WT levels of oxygen consumption in coa2⌬ cells
and Cox1 levels in the mitochondrial translation assay.
To assess the mechanism of suppression by the N196K
Cox10 in coa2⌬ cells, we showed that the mutant Cox10 lacked
any general Cox1 chaperone activity. The mutant Cox10 failed
to stabilize newly synthesized Cox1 in two CcO assembly mutants, coa1⌬ and cox4⌬ cells. The mutant and WT Cox10 were
similar in having only a modest effect in enhancing the hydrogen peroxide sensitivity of cox11⌬ cells arising from the accumulation of a prooxidant heme a3-Cox1 assembly intermediate. If the mutant Cox10 had a general stabilizing effect on
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FIG. 8. Suppression of the coa2⌬ respiratory defect by deletion of
OMA1. (A) WT cells, coa2⌬ cells, coa2⌬ yta12⌬ cells transformed with
YCp Yta12(E614Q), coa2⌬ oma1⌬ cells, and coa2⌬ yme1⌬ cells were
grown in SC–2% raffinose–0.2% glucose, serially diluted, and spotted
onto SC–2% glucose, SC–2% glycerol–2% lactate, and yeast extract–
peptone–2% glycerol-2% lactate. The plates were incubated at 30°C
for 2 days (glucose) or 6 days (glycerol-lactate). (B) WT, coa2⌬,
oma1⌬, and coa2⌬ oma1⌬ cells were grown overnight in SC–1% glucose, and oxygen consumption (% O2/second/OD600 unit) was measured. The data represent the averages of three independent repeats,
and the error bars represent standard errors of the means. (C) Purified
mitochondria (100 g protein) from WT or coa2⌬ cells expressing an
endogenously tagged COX10-13Myc, coa2⌬ cells expressing WT
Cox10-13Myc or N196K Cox10-13Myc, or coa2⌬ oma1⌬ cells expressing N196K Cox10-13Myc were solubilized in buffer containing 1%
digitonin. Lysates were run on a continuous 5 to 13% gel, and complexes were separated by BN-PAGE. Cox10-13Myc was detected by
immunoblotting with anti-Myc antisera, and monomeric complex V
detected with anti-F1␤ antisera was used as a loading control. (D) A
schematic of mitochondrial IM proteases. The mAAA protease is
composed of Yta10 and Yta12, the iAAA protease is a homo-oligomer
of Yme1, and Oma1 is proposed/speculated to be a hexamer based on
previously published data (18).

Cox1, an effect would be evident in these assays. The lack of a
general stabilization effect on Cox1 was substantiated by the
inability to detect any stable interaction between Cox10 and
Cox1.
The suppressor function of the N196K Cox10 requires the
catalytic function of Cox10. An H317A mutation that abrogates Cox10 catalysis also blocks suppressor activity of the
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N196K Cox10. Likewise, the stabilization of Cox1 in the pulse
phase of the mitochondrial translation assay imparted by the
N196K Cox10 is dependent on a functional Cox15. Heme a
biosynthesis is critical for the suppressor activity, although
high-copy-number coexpression of Cox15 and the Yah1 ferredoxin, which is known to stimulate heme a formation in CcO
mutants (4), lacked suppressor activity.
Cox10 forms a high-mass ⬃370-kDa oligomeric complex as
visualized with BN gels. The abundance of the Cox10 highmass complex seen on BN gels correlates with its suppressor
activity. The complex is highly abundant in cells harboring the
N196K mutant relative to the WT protein. The complex is
intermediate in abundance in cells with a N196A Cox10 substitution, which has weaker suppressor activity than the N196K
mutant protein. Suppressor activity and formation of the highmass Cox10 complex are abrogated with an N196D substitution. Formation of the high-mass Cox10 complex is not dependent on a catalytically active enzyme as shown with the
N196K,H317A mutant Cox10. Whereas the N196K Cox10 mutant has a marked effect on the abundance of the Cox10 BN
complex, the mutant protein has no effect on the abundance of
the high-mass Cox1-containing Coa1 or Shy1 complexes. Thus,
the effect of the N196K mutant is restricted to the Cox10
complex.
Heme a biosynthesis involves both Cox10 and Cox15. Cox15
is present at nearly 10-fold-higher levels than Cox10 in yeast
(37). Therefore, Cox10 may be the limiting factor in generation
of heme a. We postulate that Cox10 has a key role in Cox1
hemylation besides its catalytic role in forming heme o. Cox10
appears to sense newly synthesized Cox1, although Cox10 does
not stably interact with Cox1. Formation of the Cox10 oligomeric complex is dependent on Cox1 at an early step in Cox1
maturation. Cells lacking Cox14 fail to form the high-mass
Mss51/Cox14-containing Cox1 complex (3, 30) and are unable
to form the Cox10 oligomeric complex despite having WT
levels of newly synthesized Cox1. In contrast, cells lacking
Coa1 retain a WT Mss51/Cox14 complex and show an oligomeric Cox10 complex with the N196K mutant Cox10 but not
the WT protein. Thus, formation of the oligomeric Cox10
complex with the WT protein appears to be dependent on the
Coa1-containing Cox1 complex, but the mutant protein can
oligomerize in the absence of Coa1. Coa1 may have a role in
promoting Cox10 oligomer formation. An attractive postulate
is that the Cox10 catalytic function is dependent on oligomerization, such that Cox10 activity is attenuated in cells lacking
Coa1 or the upstream Mss51/Cox14 factors. Previously it was
reported that heme o formation was dependent on the presence of Cox15 (4), although the mechanism by which Cox15
modulates Cox10 remains unknown. Formation of the potentially deleterious heme a moiety may be temporally coordinated with formation of a Cox1 assembly intermediate. This
may be one mechanism to minimize the deleterious effects of
stalled Cox1 assembly intermediates. Induced heme o synthesis
may rapidly lead to heme a production by the abundant Cox15
followed by heme a insertion into Cox1. No information exists
on whether heme a insertion is directly facilitated by Cox15 or
another protein.
The marked instability of Cox1 seen in coa2⌬ cells may arise
in part from an impaired addition of heme a. Cox1 spans the
IM with 12 transmembrane (TM) helices organized in six suc-
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cessive helical pairs forming a closed bundle (34). The heme a
farnesyl tail is packed between helices 1, 11, and 12. The axial
His ligands for heme a ligation come from His62 in helix 2 and
His378 in helix 10. Thus, heme a binding is expected to stabilize the Cox1 helical bundle. Impaired formation of the heme
a-Cox1 complex would therefore be expected to destabilize
Cox1, leading to rapid degradation. The N196K Cox10 may
specifically overcome the impaired hemylation of Cox1 in
coa2⌬ cells, and this may explain why the mutant Cox10 has no
gain-of-function activity in other CcO assembly mutants.
The N196K substitution in Cox10 has a dramatic effect on
the Cox10 function. Whereas a double Arg substitution in
Cox10 abrogates function, activity is restored by the addition of
the N196K substitution. The two Arg residues (R212 and
R216) are present in a matrix-facing loop of Cox10 between
TM helices 2 and 3, and Asn196 lies at the end of TM2 near the
matrix boundary. The introduced Lys in the N196K substitution may restore an important positive charge needed in catalysis. The conserved Arg residues are implicated in the binding
of the pyrophosphate moiety of the farnesyl pyrophosphate
substrate of the Cox10-related CyoE heme o synthase of E. coli
(31). Further mechanistic details on this effect are lacking,
since no structural information on Cox10 is available.
Curiously, an identical mutation corresponding to N196K
was reported in human Cox10 (N204K) from two related patients with a CcO deficiency disorder (36). Lymphocytes harboring the mutant human protein showed residual CcO activity, and the mutant protein restored respiratory growth in
cox10⌬ yeast cells when overexpressed but only limited growth
on glycerol medium in the absence of overexpression. In contrast to the yeast N196K Cox10, the human N204K mutant
Cox10 was only a weak suppressor of coa2⌬ cells (data not
shown).
The second major mechanism of suppression of the respiratory defect in coa2⌬ cells is through depletion of the Oma1
metallopeptidase. The depletion of Oma1 restored the WT
Cox10 BN complex and restored Cox1 levels seen in the mitochondrial translation assay. Oma1 was shown to function
with the mAAA protease in the degradation of a misfolded
polytopic protein, Oxa1 (18). The catalytic center of Oma1
appears to reside on the matrix side of the IM, although it
mediated an Oxa1 cleavage site also on the IMS side of the IM.
The present work clearly documents that Oma1 has a significant role in the Cox1 instability in coa2⌬ cells. The likely Oma1
substrate is Cox1 and not Cox10, since overexpression of
MSS51 partially restores the BN Cox10 complex in coa2⌬ cells
yet fails to promote respiratory growth. In addition, only the
BN Cox10 complex is depleted in coa2⌬ cells; steady-state
Cox10 levels remain normal. Thus, the observed depletion of
the high-mass Cox10 complex may arise merely from Cox1
degradation of the Coa1-containing Cox1 complex. Impaired
hemylation of Cox1 may lead to a misfolded Cox1 that is an
efficient substrate for Oma1. We previously demonstrated that
weak respiratory growth in coa2⌬ cells is induced in cells with
an attenuated mAAA. The reported proteolytic degradation of
the misfolded Oxa1 was also facilitated by a combination of
Oma1 and the mAAA protease (18). Future studies will address the substrate specificity of Oma1 and whether Oma1
depletion has similar effects on other CcO assembly mutants.
Oma1 is conserved in metazoans, so future studies will also
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address its role in Cox1 degradation in human CcO deficiency
mutants.
The two mechanisms of suppression of coa2⌬ cells have
implications for the physiological function of Coa2 in CcO
biogenesis. The robust suppressor function of N196K Cox10
suggests that Coa2 functions in part in a step related to heme
a addition to Cox1. Cells lacking Coa2 fail to form the oligomeric Cox10 complex as well as the Cox1 assembly intermediates containing Coa1 and Shy1. Coa2 may impart stability to
the oligomeric Cox10 complex. It is unlikely that Coa2 imparts
stability to the Coa1-containing Cox1 complex, as Coa2 and
Coa1 do not interact. In contrast, Coa2 forms a transient interaction with Shy1 and may contribute to its stability (29) as
well as the Cox10 complex. Shy1 stabilizes the Cox1 assembly
intermediate in which the CuB-heme a3 bimetallic center is
formed (29). In the absence of Coa2, formation of the heme a
and CuB-heme a3 centers occurs to a limited extent, leading to
low levels of the prooxidant heme a3-Cox1 intermediate that
confers weak hydrogen peroxide sensitivity. Thus, Coa2 is not
essential for formation of the redox centers. Future studies will
address whether Coa1 and/or Coa2 mediates Cox10 oligomerization.
A second function of Coa2 involves the apparent stabilization of Cox1 during its maturation. This may arise either from
a direct effect on Cox1 or indirectly by modulating a protease
such as Oma1. Newly synthesized Cox1 is less stable in coa2⌬
cells than in cox10⌬ cells. Although Cox1 appears to be rapidly
degraded in coa2⌬ and cox10⌬ cells (Fig. 1F), two other studies reported the appearance of newly synthesized Cox1 in mitochondrial translation assays performed on cox10⌬ cells (3,
25). The differences in Cox1 levels seen during the pulse phase
of the translation assay in the two null strains must relate to
enhanced proteolysis in coa2⌬ cells. Coa2 may be a negative
regulator of a protease such as Oma1. Future studies will
directly assess the role of Coa2 in IM proteolysis.
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